المؤلفون: Lorente, David, Olmos, David, Mateo, Joaquin, Bianchini, Diletta, Seed, George, Fleisher, Martin, Danila, Daniel C., Flohr, Penny, Crespo, Mateus, Figueiredo, Ines, Miranda, Susana, Baeten, Kurt, Molina, Arturo, Kheoh, Thian, McCormack, Robert, Terstappen, Leon W. M. M., Scher, Howard I., de Bono, Johann S.

المساهمون: Lorente, David Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Mateo, Joaquin Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Bianchini, Diletta Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Seed, George Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Flohr, Penny Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Crespo, Mateus Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Figueiredo, Ines Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Miranda, Susana Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, de Bono, Johann S. Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, Lorente, David Inst Canc Res, Sutton, Surrey, England, Mateo, Joaquin Inst Canc Res, Sutton, Surrey, England, Bianchini, Diletta Inst Canc Res, Sutton, Surrey, England, Seed, George Inst Canc Res, Sutton, Surrey, England, Flohr, Penny Inst Canc Res, Sutton, Surrey, England, Crespo, Mateus Inst Canc Res, Sutton, Surrey, England, Figueiredo, Ines Inst Canc Res, Sutton, Surrey, England, Miranda, Susana Inst Canc Res, Sutton, Surrey, England, de Bono, Johann S. Inst Canc Res, Sutton, Surrey, England, Olmos, David Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain, Fleisher, Martin Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, Danila, Daniel C. Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, Scher, Howard I. Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, Baeten, Kurt Janssen Diagnost, Med Affairs, Beerse, Belgium, Molina, Arturo Janssen Res & Dev, Menlo Pk, CA USA, McCormack, Robert Janssen Res & Dev, Menlo Pk, CA USA, Kheoh, Thian Janssen Res & Dev, La Jolla, CA USA, Terstappen, Leon W. M. M. Univ Twente, MIRA Res Inst Biomed Technol & Tech Med, Twente, Netherlands, Lorente, David Hosp Univ La Fe, Med Oncol Serv, Valencia, Spain, Olmos, David Hosp Univ Virgen de la Victoria, CNIO IBIMA Genitourinary Canc Unit, Dept Med Oncol, Malaga, Spain, Olmos, David Hosp Univ Reg Malaga, CNIO IBIMA Genitourinary Canc Unit, Dept Med Oncol, Malaga, Spain, Movember/Prostate Cancer UK Centre of Excellence Program grant, FP7 EU grant, Medical Research Council, MRC, NATIONAL CANCER INSTITUTE

مصطلحات موضوعية: Castration-resistant prostate cancer, Treatment outcome, Response, Circulating tumor cells, Abiraterone, Chemotherapy, Abiraterone acetate, Increased survival, End-points, Enzalutamide, Antigen, Trial, Surrogacy, Docetaxel, Biomarker, Androstenes, Antineoplastic Combined Chemotherapy Protocols, Cell Count, Clinical Trials as Topic, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Multivariate Analysis, Neoplasm Metastasis, Neoplastic Cells, Circulating, Prednisone, Proportional Hazards Models, Prostatic Neoplasms

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/18775Test; http://www.europeanurology.com/article/S0302283816301877/pdfTest; 390563100028

الإتاحة: https://doi.org/10.1016/j.eururo.2016.05.023Test
http://hdl.handle.net/10668/18775Test
http://www.europeanurology.com/article/S0302283816301877/pdfTest

المؤلفون: Kloeppel, S, Gregory, S, Scheller, E, Minkova, L, Razi, A, Durr, A, Roos, RAC, Leavitt, BR, Papoutsi, M, Landwehrmeyer, GB, Reilmann, R, Borowsky, B, Johnson, H, Mills, JA, Owen, G, Stout, J, Scahill, RI, Long, JD, Rees, G, Tabrizi, SJ

المصدر: EBioMedicine , 2 (10) pp. 1420-1429. (2015)

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, Research & Experimental, General & Internal Medicine, Research & Experimental Medicine, Huntington's disease, Preclinical, Neural compensation, MRI, Cognitive, Motor, GRAY-MATTER LOSS, OBSERVATIONAL DATA, WORKING-MEMORY, END-POINTS, IMAGE-HD, PREMANIFEST, MECHANISMS, METAANALYSIS, PATHOLOGY, TRIALS

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/1484937/1/Rees_Compensation%20in%20Preclinical%20Huntington%27s%20Disease%253A%20Evidence%20From%20the%20Track-On%20HD%20Study.pdfTest; https://discovery.ucl.ac.uk/id/eprint/1484937Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/1484937/1/Rees_Compensation%20in%20Preclinical%20Huntington%27s%20Disease%253A%20Evidence%20From%20the%20Track-On%20HD%20Study.pdfTest
https://discovery.ucl.ac.uk/id/eprint/1484937Test/

المؤلفون: Daniel C. Danila, Johann S. de Bono, Mateus Crespo, David Olmos, Ines Figueiredo, Kurt Baeten, George Seed, Robert T. McCormack, Arturo Molina, Susana Miranda, Thian Kheoh, Howard I. Scher, Penny Flohr, Diletta Bianchini, Leon W.M.M. Terstappen, David Lorente, Joaquin Mateo, Martin Fleisher

المساهمون: [Lorente, David] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Mateo, Joaquin] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Bianchini, Diletta] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Seed, George] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Flohr, Penny] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Crespo, Mateus] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Figueiredo, Ines] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Miranda, Susana] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton, Surrey, England, [Lorente, David] Inst Canc Res, Sutton, Surrey, England, [Mateo, Joaquin] Inst Canc Res, Sutton, Surrey, England, [Bianchini, Diletta] Inst Canc Res, Sutton, Surrey, England, [Seed, George] Inst Canc Res, Sutton, Surrey, England, [Flohr, Penny] Inst Canc Res, Sutton, Surrey, England, [Crespo, Mateus] Inst Canc Res, Sutton, Surrey, England, [Figueiredo, Ines] Inst Canc Res, Sutton, Surrey, England, [Miranda, Susana] Inst Canc Res, Sutton, Surrey, England, [de Bono, Johann S.] Inst Canc Res, Sutton, Surrey, England, [Olmos, David] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain, [Fleisher, Martin] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, [Danila, Daniel C.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, [Scher, Howard I.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA, [Baeten, Kurt] Janssen Diagnost, Med Affairs, Beerse, Belgium, [Molina, Arturo] Janssen Res & Dev, Menlo Pk, CA USA, [McCormack, Robert] Janssen Res & Dev, Menlo Pk, CA USA, [Kheoh, Thian] Janssen Res & Dev, La Jolla, CA USA, [Terstappen, Leon W. M. M.] Univ Twente, MIRA Res Inst Biomed Technol & Tech Med, Twente, Netherlands, [Lorente, David] Hosp Univ La Fe, Med Oncol Serv, Valencia, Spain, [Olmos, David] Hosp Univ Virgen de la Victoria, CNIO IBIMA Genitourinary Canc Unit, Dept Med Oncol, Malaga, Spain, [Olmos, David] Hosp Univ Reg Malaga, CNIO IBIMA Genitourinary Canc Unit, Dept Med Oncol, Malaga, Spain, Movember/Prostate Cancer UK Centre of Excellence Program grant, FP7 EU grant, Medical Research Council, MRC, NATIONAL CANCER INSTITUTE, Medical Cell Biophysics, Faculty of Science and Technology

المصدر: EUROPEAN UROLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
European urology, 70(6), 985-992. Elsevier

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_treatment, Cell Count, Kaplan-Meier Estimate, Docetaxel, Trial, Prostate cancer, Increased survival, 0302 clinical medicine, Circulating tumor cell, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Treatment outcome, Abiraterone, METIS-318832, Castration-resistant prostate cancer, Clinical Trials as Topic, Hazard ratio, Response, IR-103825, Neoplastic Cells, Circulating, Abiraterone acetate, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, Antigen, Androstenes, Surrogacy, medicine.medical_specialty, Urology, 03 medical and health sciences, Internal medicine, medicine, Enzalutamide, Humans, Chemotherapy, Proportional Hazards Models, business.industry, Proportional hazards model, Circulating tumor cells, Biomarker, medicine.disease, Confidence interval, Surgery, Clinical trial, 030104 developmental biology, Logistic Models, Multivariate Analysis, End-points, Prednisone, Cancer biomarkers, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2854f01004b212e846268ec87cad1aecTest
http://www.europeanurology.com/article/S0302283816301877/pdfTest